GNTA (Genenta Science S.p.A.) Stock Market Reviews

crown

search

Read and share opinions on GNTA (Genenta Science S.p.A.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

GNTA

Genenta Science S.p.A.

clarify Biotechnology

bookmark Healthcare

public Italy

Sell Neutral Buy

Latest News

Genenta Science (GNTA): Assessing Valuation After Expanded Anemocyte Partnership Spurs Industry Optimism
Oct 27, 2025
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
Oct 27, 2025
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
Oct 24, 2025
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
Jul 1, 2025
Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference
May 8, 2025
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
May 7, 2025
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
Apr 15, 2025
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
Mar 19, 2025
Is Genenta Science S.p.A. (GNTA) the Best Italian Stock to Buy in 2025?
Feb 13, 2025
Genenta Science announces amendment to pact with AGC Biologics
Jan 10, 2025
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
Jan 9, 2025

Reviews